# Combined Optical and Infrared Imaging for Early Prediction of Erythema During Breast and Chestwall Radiotherapy

> **NCT04363892** · NA · TERMINATED · sponsor: **Nova Scotia Health Authority** · enrollment: 7 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Optical and infrared imaging

## Key facts

- **NCT ID:** NCT04363892
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-07-01
- **Primary completion:** 2021-06-14
- **Final completion:** 2021-06-14
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** The PI resigned
- **Last updated:** 2024-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04363892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04363892, "Combined Optical and Infrared Imaging for Early Prediction of Erythema During Breast and Chestwall Radiotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04363892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*